A detailed history of Strs Ohio transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 10,600 shares of DYN stock, worth $358,598. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,600
Previous 20,400 48.04%
Holding current value
$358,598
Previous $579,000 35.41%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$23.65 - $35.63 $231,770 - $349,174
-9,800 Reduced 48.04%
10,600 $374,000
Q1 2024

May 13, 2024

BUY
$13.06 - $29.18 $266,424 - $595,272
20,400 New
20,400 $579,000
Q1 2023

Aug 02, 2023

BUY
$10.88 - $15.0 $143,616 - $198,000
13,200 New
13,200 $152,000
Q3 2022

Oct 27, 2022

BUY
$7.2 - $15.17 $95,040 - $200,244
13,200 New
13,200 $167,000
Q1 2021

Apr 23, 2021

SELL
$14.0 - $29.3 $49,000 - $102,550
-3,500 Closed
0 $0
Q4 2020

Jan 25, 2021

BUY
$16.81 - $23.94 $58,834 - $83,790
3,500 New
3,500 $73,000

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.75B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.